Department of Molecular Medicine, Sapienza University of Rome, 00161 Roma, Italy.
Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy.
Int J Mol Sci. 2022 Jan 13;23(2):829. doi: 10.3390/ijms23020829.
Acute lymphoblastic leukaemia (ALL) is an aggressive haematological tumour driven by the malignant transformation and expansion of B-cell (B-ALL) or T-cell (T-ALL) progenitors. The evolution of T-ALL pathogenesis encompasses different master developmental pathways, including the main role played by Notch in cell fate choices during tissue differentiation. Recently, a growing body of evidence has highlighted epigenetic changes, particularly the altered expression of microRNAs (miRNAs), as a critical molecular mechanism to sustain T-ALL. The immune response is emerging as key factor in the complex multistep process of cancer but the role of miRNAs in anti-leukaemia response remains elusive. In this review we analyse the available literature on miRNAs as tuners of the immune response in T-ALL, focusing on their role in Natural Killer, T, T-regulatory and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the leukemia field.
急性淋巴细胞白血病(ALL)是一种侵袭性血液系统肿瘤,由 B 细胞(B-ALL)或 T 细胞(T-ALL)前体细胞的恶性转化和扩增驱动。T-ALL 发病机制的演变包含不同的主要发育途径,包括 Notch 在组织分化过程中细胞命运选择中的主要作用。最近,越来越多的证据强调了表观遗传变化,特别是 microRNAs(miRNAs)的表达改变,作为维持 T-ALL 的关键分子机制。免疫反应是癌症复杂多步骤过程中的关键因素,但 miRNA 在抗白血病反应中的作用仍不清楚。在这篇综述中,我们分析了 miRNA 作为 T-ALL 中免疫反应调节剂的现有文献,重点关注它们在自然杀伤细胞、T 细胞、T 调节细胞和髓源抑制细胞中的作用。对这种分子串扰的更好理解可能为白血病领域潜在免疫治疗策略的发展提供基础。
Int J Mol Sci. 2022-1-13
Hum Immunol. 2021-9
Technol Cancer Res Treat. 2020
Int J Mol Sci. 2024-11-29
Int J Mol Sci. 2024-2-5
Immunol Rev. 2021-11
Int J Mol Sci. 2021-5-18
Hum Immunol. 2021-9
Am J Cancer Res. 2021-4-15
Cancers (Basel). 2021-3-26
Curr Probl Cancer. 2021-10